ALHC vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 29, 2026

ALHC

66.2
AI Score
VS
ALHC Wins

CLOV

56.6
AI Score

Investment Advisor Scores

ALHC

66score
Recommendation
BUY

CLOV

57score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ALHC CLOV Winner
Forward P/E 204.0816 81.9672 CLOV
PEG Ratio 0 0 Tie
Revenue Growth 33.3% 62.0% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 66.2/100 56.6/100 ALHC
Profit Margin 0.5% -2.6% ALHC
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD ALHC

Frequently Asked Questions

Based on our detailed analysis, ALHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.